EPRS

EPIRUS BIOPHARMACEUTICALS INC COM
EPRS

Overview Fund Activity
Delisted

EPRS was delisted on the 3rd of August, 2016.

Back to rankings

32 hedge funds and large institutions have $2.6M invested in EPIRUS BIOPHARMACEUTICALS INC COM in 2016 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 14 closing their positions.

Holders
32
Holders Change
-5
Holders Change %
-13.51%
% of All Funds
0.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
4
Reduced
8
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VKH
1
Virtu KCG Holdings
New York
$59K
2
TSS
2
Two Sigma Securities
New York
$18K
3
Goldman Sachs
3
Goldman Sachs
New York
$8K
4
UBS Group
4
UBS Group
Switzerland
$4K
5
HCM
5
Horrell Capital Management
Arkansas
$1K

Top Sellers

1
Jennison Associates
1
Jennison Associates
New York
$0
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$0
3
BC
3
Broadfin Capital
New York
$0
4
CAM
4
Cormorant Asset Management
Massachusetts
$0
5
B
5
Bailard
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
B
26
Bailard
California
– -$1.63M -604,500 Closed
Millennium Management
27
Millennium Management
New York
– -$1.11M -411,111 Closed
HCMT
28
Highland Capital Management (Texas)
Texas
– -$512K -190,033 Closed
SM
29
Southport Management
Wyoming
– -$135K -50,000 Closed
NFA
30
Nationwide Fund Advisors
Ohio
– -$94K -35,000 Closed
SCM
31
Sterling Capital Management
North Carolina
– -$33K -12,331 Closed
M&T Bank
32
M&T Bank
New York
– -$31K -11,701 Closed
Citadel Advisors
33
Citadel Advisors
Florida
– -$28K -10,359 Closed
BIM
34
BlackRock Investment Management
Delaware
– -$8K -3,015 Closed
TRCT
35
Tower Research Capital (TRC)
New York
– -$3K -1,288 Closed
1
2